Alliance for Vascular Access Teaching and Research - Avatar Group

27/11/2025

💥 CHG vs PVI – Which Antiseptic Wins?

Is chlorhexidine really the gold standard? This review compares CHG and povidone-iodine across safety, resistance, cost & environment.
🔗 Read more: https://www.avatargroup.org.au/blog/chlorhexidine-vs-povidone-iodine-for-catheter-infection-prevention--which-is-better-

26/11/2025

https://www.medscape.com/viewarticle/routinely-maintaining-iv-catheter-access-time-mindset-shift-2025a1000v8h?form=fpf

The practice of routinely maintaining PIVC access has not only benefits but also risks. It’s due for a mindset shift, with focus on monitoring and reassessment daily, experts say.

26/11/2025

Ready to turn your ideas into real clinical impact? 💡💉

AVATAR is offering Higher Degree by Research (HDR) opportunities in vascular access and infusion therapy, connecting you with expert supervisors across universities and specialties.

👉 Learn more and submit an EOI: https://forms.office.com/Pages/ResponsePage.aspx?id=q8h8Wtykm0-_YGZxQEmtYu7XRycZCrVFgePL8G1IpjFUNDlHTzVPSkFTWFlPS001QlJKVEFaSFVRNC4u

21/11/2025

Exciting news for vascular access and infection prevention in Australia 👏

Congratulations to ACIPC and the Australian Vascular Access Society (AVAS) on the launch of the Vascular Access Special Interest Group (VASIG) 🎉

VASIG will bring vascular access and infection prevention experts together to share knowledge, drive education and research, and strengthen evidence-based practice in line with NSQHS Standard 3.

We look forward to the guidelines, education and research that will grow from this work and ultimately benefit patients across Australia.

20/11/2025

📌 ECMO Cannulae: Are We Doing Enough?

From suture types to dressing variations—this point prevalence study reveals major inconsistencies in ECMO cannula securement across AU/NZ. It's time for ECMO-specific guidelines.
🔗 Read more: https://www.avatargroup.org.au/blog/securing-ecmo-cannulae--is-it-time-for-evidence-based-guidelines-

18/11/2025

Have questions or need support?

Get in touch with AVATAR! For general inquiries, reach out to us here: https://www.avatargroup.org.au/contact-us---general-inquiry.html

Industry partners, sponsors, and business-related queries, contact our industry engagement team here: https://www.avatargroup.org.au/contact-us---industry-query.html

13/11/2025

Australia's PIVC care still causes avoidable harm. This priority-setting study outlines 9 actionable strategies to transform infection control, clinical training, and patient engagement.

👉 Read more: https://www.avatargroup.org.au/blog/setting-the-national-agenda-for-better-pivc-care-in-australia

11/11/2025

Discover AVATAR's cutting-edge solutions in vascular access, designed to enhance patient outcomes and streamline clinical workflows.

Explore tools like the I-DECIDED® checklist and IV Passport app, setting new standards in patient care.

Explore now: https://www.avatargroup.org.au/innovations.html

06/11/2025

Repeated IV attempts in neonates are more common than you think. A recent case series shows that extremely low birth weight babies often require multiple PIVCs, many of which fail early. It's time to rethink vascular access decisions in NICU care.

👉 Read the full blog: https://www.avatargroup.org.au/blog/recurrent-pivc-use-in-neonates--a-case-for-better-device-selection

04/11/2025

📚 Looking for the latest research on vascular access care?

Search any AVATAR publication by title, author, or topic — it’s quick and easy!
👉 Start here: https://www.avatargroup.org.au/our-publications.html

30/10/2025

💡 With IV therapy complications on the rise, Infusion and Vascular Access Teams (IVADs) are emerging as a solution. This article explores how coordinated, specialised teams can improve outcomes, reduce complications, and support aging healthcare systems.

👉 Learn how we can prepare for the future: https://www.avatargroup.org.au/blog/vascular-access-teams--a-key-strategy-for-the-future-of-intravenous-therapy

29/10/2025

Every patient deserves safe, effective, and innovative vascular access care. Your donation directly funds cutting-edge research that reduces complications like infections and blockages, supports clinicians with advanced resources, and drives life-saving medical breakthroughs.

With 100% of your contribution going to research—no admin fees—every dollar makes a difference. Be a part of healthcare innovation and help us improve patient outcomes worldwide.

Donate today: https://www.avatargroup.org.au/donate-now.html